Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes

It is postulated that central effects of angiotensin (Ang) II may be indirect due to rapid conversion to Ang III by aminopeptidase A (APA). Previously, we showed that Ang II and Ang III induced mitogen-activated protein (MAP) kinases ERK1/2 and stress-activated protein kinase/Jun-terminal kinases (S...

Full description

Saved in:
Bibliographic Details
Main Authors: Michelle A. Clark, Chinh Nguyen, Hieu Tran
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2013/782861
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561106104614912
author Michelle A. Clark
Chinh Nguyen
Hieu Tran
author_facet Michelle A. Clark
Chinh Nguyen
Hieu Tran
author_sort Michelle A. Clark
collection DOAJ
description It is postulated that central effects of angiotensin (Ang) II may be indirect due to rapid conversion to Ang III by aminopeptidase A (APA). Previously, we showed that Ang II and Ang III induced mitogen-activated protein (MAP) kinases ERK1/2 and stress-activated protein kinase/Jun-terminal kinases (SAPK/JNK) phosphorylation in cultured rat astrocytes. Most importantly, both peptides were equipotent in causing phosphorylation of these MAP kinases. In these studies, we used brainstem and cerebellum astrocytes to determine whether Ang II’s phosphorylation of these MAP kinases is due to the conversion of the peptide to Ang III. We pretreated astrocytes with 10 μM amastatin A or 100 μM glutamate phosphonate, selective APA inhibitors, prior to stimulating with either Ang II or Ang III. Both peptides were equipotent in stimulating ERK1/2 and SAPK/JNK phosphorylation. The APA inhibitors failed to prevent Ang II- and Ang III-mediated phosphorylation of the MAP kinases. Further, pretreatment of astrocytes with the APA inhibitors did not affect Ang II- or Ang III-induced astrocyte growth. These findings suggest that both peptides directly induce phosphorylation of these MAP kinases as well as induce astrocyte growth. These studies establish both peptides as biologically active with similar intracellular and physiological effects.
format Article
id doaj-art-a02c4f7baa97466b8250230e15dd39f1
institution Kabale University
issn 2090-0384
2090-0392
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-a02c4f7baa97466b8250230e15dd39f12025-02-03T01:25:54ZengWileyInternational Journal of Hypertension2090-03842090-03922013-01-01201310.1155/2013/782861782861Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat AstrocytesMichelle A. Clark0Chinh Nguyen1Hieu Tran2Department of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328, USAIt is postulated that central effects of angiotensin (Ang) II may be indirect due to rapid conversion to Ang III by aminopeptidase A (APA). Previously, we showed that Ang II and Ang III induced mitogen-activated protein (MAP) kinases ERK1/2 and stress-activated protein kinase/Jun-terminal kinases (SAPK/JNK) phosphorylation in cultured rat astrocytes. Most importantly, both peptides were equipotent in causing phosphorylation of these MAP kinases. In these studies, we used brainstem and cerebellum astrocytes to determine whether Ang II’s phosphorylation of these MAP kinases is due to the conversion of the peptide to Ang III. We pretreated astrocytes with 10 μM amastatin A or 100 μM glutamate phosphonate, selective APA inhibitors, prior to stimulating with either Ang II or Ang III. Both peptides were equipotent in stimulating ERK1/2 and SAPK/JNK phosphorylation. The APA inhibitors failed to prevent Ang II- and Ang III-mediated phosphorylation of the MAP kinases. Further, pretreatment of astrocytes with the APA inhibitors did not affect Ang II- or Ang III-induced astrocyte growth. These findings suggest that both peptides directly induce phosphorylation of these MAP kinases as well as induce astrocyte growth. These studies establish both peptides as biologically active with similar intracellular and physiological effects.http://dx.doi.org/10.1155/2013/782861
spellingShingle Michelle A. Clark
Chinh Nguyen
Hieu Tran
Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
International Journal of Hypertension
title Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
title_full Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
title_fullStr Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
title_full_unstemmed Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
title_short Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
title_sort distinct molecular effects of angiotensin ii and angiotensin iii in rat astrocytes
url http://dx.doi.org/10.1155/2013/782861
work_keys_str_mv AT michelleaclark distinctmoleculareffectsofangiotensiniiandangiotensiniiiinratastrocytes
AT chinhnguyen distinctmoleculareffectsofangiotensiniiandangiotensiniiiinratastrocytes
AT hieutran distinctmoleculareffectsofangiotensiniiandangiotensiniiiinratastrocytes